- Article
Topical Pioglitazone Nanoformulation for the Treatment of Atopic Dermatitis: Design, Characterization and Efficacy in Hairless Mouse Model
- Lupe Carolina Espinoza,
- Rodrigo Vera-García,
- Marcelle Silva-Abreu,
- Òscar Domènech,
- Josefa Badia,
- María J. Rodríguez-Lagunas,
- Beatriz Clares and
- Ana Cristina Calpena
Pioglitazone (PGZ) is a drug used to treat type 2 diabetes mellitus that has been reported to show additional therapeutic activities on diverse inflammatory parameters. The aim of this study was to optimize a topical PGZ-loaded nanoemulsion (PGZ-NE)...

